The Wistar Institute's Paul M. Lieberman, Ph.D. and lab identified and tested a new method for targeting certain cancers ...

New research highlights a critical link between antibodies produced against Epstein-Barr virus (EBV) and the development of ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

In multiple sclerosis (MS), antibodies to the common Epstein-Barr virus can accidentally attack a protein in the brain and ...

An estimated 90 to 95 percent of adults are carriers of the Epstein-Barr virus (EBV) and have formed antibodies against it. Many become infected as children with few or no symptoms, but in young ...

Crohn's disease is a type of inflammatory bowel disease, and the causes are unclear. Now resarch has shown it may be related ...

A small U.S. study explored whether immune markers seen in many long COVID sufferers are also present in people with ...

New research shows that the combination of certain viral antibodies and genetic risk factors can be linked to a greatly ...

An immune profile consistent with the eactivation of the Epstein-Barr virus was observed in MS patients prior to a disease ...

T-cell lymphoma is a rare cancer that affects the lymphatic system. Learn about the types, signs, symptoms, treatments, and ...

Half of the patients in a small trial for an experimental pancreatic cancer vaccine by Roche and BioNTech showed survival ...

Epstein-Barr virus (EBV), best known as the virus behind mono, has been linked to various autoimmune disorders later in life, including lupus, multiple sclerosis, and rheumatoid arthritis. Now, a ...